科学家确定数百个遗传变异,为遗传性乳腺癌风险提供新见解
Scientists pinpoint hundreds of genetic variants that offer new insights into inherited breast cancer risk
研究人员通过大规模实验确定了数百个遗传变异,这些变异可能影响乳腺癌风险。研究发现,CCDC88C基因可能与乳腺癌风险有关,其活性在雌激素受体阳性乳腺癌中较高,与更好的生存率相关。
Scientists have carried out one of the largest experimental studies of breast cancer variants to date, helping pinpoint genetic changes that are most likely to contribute to the development of the disease.
The study, led by a team at The Institute of Cancer Research, London, analyzed over 5,000 genetic variants linked to breast cancer risk, identifying over 700 across 140 risk regions appearing to alter gene activity. One gene emerged as a likely target of a particular risk variant, with its activity linked to a breast cancer subtype.
The findings, published in the journal Human Genetics and Genomics Advances, provide a prioritized list of variants for future investigation and offer new insights into the genetic changes that contribute to inherited breast cancer risk.
Looking beyond genetic associations
Breast cancer has a strong heritable basis, meaning some of a person's risk of developing the disease can be inherited through their genes.
Researchers have already identified 196 regions of DNA associated with breast cancer, but determining exactly which genetic variants within those regions are responsible, and how they influence disease risk, remains a major challenge. Many of these variants are found in noncoding regions of DNA, meaning that instead of directly altering proteins, they can influence how genes are regulated and expressed.
To investigate the variants most likely to have a biological effect, the research team used a high-throughput technique, known as a 'massively parallel reporter assay,' to simultaneously test 5,116 candidate variants that had previously been identified through large collaborative breast cancer risk genetic studies. This allowed them to assess whether different versions of each variant affected nearby DNA sequences that regulate gene activity.
Of those screened, 709 showed significant differences in regulatory activity in T-47D breast cancer cells, suggesting they may play a functional role in influencing cancer risk.
Uncovering a potential role
Through laboratory follow-up analysis, the team identified CCDC88C as a likely target of a risk variant called rs7153397. The variant appeared to affect the regulation of CCDC88C, a gene previously linked to breast cancer progression and metastasis, suggesting a potential mechanism through which the variant could influence breast cancer risk.
The team also analyzed tumor data from thousands of patients and found that CCDC88C activity was higher in estrogen receptor-positive (ER+) breast cancers than in the estrogen receptor-negative (ER-) tumors. Among patients with ER+ breast cancer, higher levels of CCDC88C were also associated with improved survival.
Improving understanding of breast cancer risk
With a refined list of risk variants, breast cancer researchers can now prioritize which of those should be studied in greater detail.
First author Kate Mackie, a Ph.D. student in the Division of Breast Cancer Research at The Institute of Cancer Research (ICR) at the time of the study, said, "It's rewarding to see our approach pinpoint promising variants with demonstrable regulatory effects for future investigation. Next steps would include investigating the additional variants highlighted by the study, exploring how their effects differ across breast cancer subtypes and cell types, and studying the biological role of CCDC88C in greater detail."
Senior author Dr. Syed Haider, leader of the Breast Cancer Data Science Group in the Division of Breast Cancer Research, said, "While our work alone cannot identify causal variants and gene targets for the reported 196 breast cancer risk regions, our intricate research provides a clearer understanding of the biological pathways involved in breast cancer susceptibility, particularly CCDC88C's role in the biology of ER+ breast cancer—contributing to improved risk prediction and potentially unraveling new therapeutic opportunities for patients."
More information
Kate Mackie et al., Massively parallel functional profiling prioritizes breast cancer risk variants and implicates CCDC88C in ER-positive breast cancer, Human Genetics and Genomics Advances (2026). DOI: 10.1016/j.xhgg.2026.100674
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Scientists pinpoint hundreds of genetic variants that offer new insights into inherited breast cancer risk (2026, November 5) retrieved 5 November 2026 from https://medicalxpress.com/news/2026-11-scientists-hundreds-genetic-variants-insights.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com